These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 23551094)

  • 1. Role of SHIP1 in cancer and mucosal inflammation.
    Fernandes S; Iyer S; Kerr WG
    Ann N Y Acad Sci; 2013 Mar; 1280(1):6-10. PubMed ID: 23551094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukemia-associated mutations in SHIP1 inhibit its enzymatic activity, interaction with the GM-CSF receptor and Grb2, and its ability to inactivate PI3K/AKT signaling.
    Brauer H; Strauss J; Wegner W; Müller-Tidow C; Horstmann M; Jücker M
    Cell Signal; 2012 Nov; 24(11):2095-101. PubMed ID: 22820502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms controlling membrane recruitment and activation of the autoinhibited SHIP1 inositol 5-phosphatase.
    Waddell GL; Drew EE; Rupp HP; Hansen SD
    J Biol Chem; 2023 Aug; 299(8):105022. PubMed ID: 37423304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Src homology 2 domain-containing inositol-5-phosphatase 1 (SHIP1) negatively regulates TLR4-mediated LPS response primarily through a phosphatase activity- and PI-3K-independent mechanism.
    An H; Xu H; Zhang M; Zhou J; Feng T; Qian C; Qi R; Cao X
    Blood; 2005 Jun; 105(12):4685-92. PubMed ID: 15701712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of SHIP1 in bone biology.
    Iyer S; Margulies BS; Kerr WG
    Ann N Y Acad Sci; 2013 Mar; 1280():11-4. PubMed ID: 23551095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small-molecule agonists of SHIP1 inhibit the phosphoinositide 3-kinase pathway in hematopoietic cells.
    Ong CJ; Ming-Lum A; Nodwell M; Ghanipour A; Yang L; Williams DE; Kim J; Demirjian L; Qasimi P; Ruschmann J; Cao LP; Ma K; Chung SW; Duronio V; Andersen RJ; Krystal G; Mui AL
    Blood; 2007 Sep; 110(6):1942-9. PubMed ID: 17502453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SHIP1 and its role for innate immune regulation-Novel targets for immunotherapy.
    Yeoh WJ; Krebs P
    Eur J Immunol; 2023 Dec; 53(12):e2350446. PubMed ID: 37742135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silencer of death domains (SODD) inhibits skeletal muscle and kidney enriched inositol 5-phosphatase (SKIP) and regulates phosphoinositide 3-kinase (PI3K)/Akt signaling to the actin cytoskeleton.
    Rahman P; Huysmans RD; Wiradjaja F; Gurung R; Ooms LM; Sheffield DA; Dyson JM; Layton MJ; Sriratana A; Takada H; Tiganis T; Mitchell CA
    J Biol Chem; 2011 Aug; 286(34):29758-70. PubMed ID: 21712384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic potential of SH2 domain-containing inositol-5'-phosphatase 1 (SHIP1) and SHIP2 inhibition in cancer.
    Fuhler GM; Brooks R; Toms B; Iyer S; Gengo EA; Park MY; Gumbleton M; Viernes DR; Chisholm JD; Kerr WG
    Mol Med; 2012 Feb; 18(1):65-75. PubMed ID: 22033675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The termination of PI3K signalling by SHIP1 and SHIP2 inositol 5-phosphatases.
    Backers K; Blero D; Paternotte N; Zhang J; Erneux C
    Adv Enzyme Regul; 2003; 43():15-28. PubMed ID: 12791379
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of SHIP1 in T-lymphocyte life and death.
    Gloire G; Erneux C; Piette J
    Biochem Soc Trans; 2007 Apr; 35(Pt 2):277-80. PubMed ID: 17371259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The inositol 5-phosphatase SHIP1 is a nucleo-cytoplasmic shuttling protein and enzymatically active in cell nuclei.
    Nalaskowski MM; Metzner A; Brehm MA; Labiadh S; Brauer H; Grabinski N; Mayr GW; Jücker M
    Cell Signal; 2012 Mar; 24(3):621-8. PubMed ID: 21864674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SHIP1 regulates MSC numbers and their osteolineage commitment by limiting induction of the PI3K/Akt/β-catenin/Id2 axis.
    Iyer S; Viernes DR; Chisholm JD; Margulies BS; Kerr WG
    Stem Cells Dev; 2014 Oct; 23(19):2336-51. PubMed ID: 24857423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SHIP1, an SH2 domain containing polyinositol-5-phosphatase, regulates migration through two critical tyrosine residues and forms a novel signaling complex with DOK1 and CRKL.
    Sattler M; Verma S; Pride YB; Salgia R; Rohrschneider LR; Griffin JD
    J Biol Chem; 2001 Jan; 276(4):2451-8. PubMed ID: 11031258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of the Src homology 2 domain-containing inositol 5'-phosphatase (SHIP1) by the cyclic AMP-dependent protein kinase.
    Zhang J; Walk SF; Ravichandran KS; Garrison JC
    J Biol Chem; 2009 Jul; 284(30):20070-8. PubMed ID: 19494109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Functional Roles of the Src Homology 2 Domain-Containing Inositol 5-Phosphatases SHIP1 and SHIP2 in the Pathogenesis of Human Diseases.
    Müller SM; Jücker M
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired T-cell survival promotes mucosal inflammatory disease in SHIP1-deficient mice.
    Park MY; Srivastava N; Sudan R; Viernes DR; Chisholm JD; Engelman RW; Kerr WG
    Mucosal Immunol; 2014 Nov; 7(6):1429-1439. PubMed ID: 24781051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control of cell polarity and motility by the PtdIns(3,4,5)P3 phosphatase SHIP1.
    Nishio M; Watanabe K; Sasaki J; Taya C; Takasuga S; Iizuka R; Balla T; Yamazaki M; Watanabe H; Itoh R; Kuroda S; Horie Y; Förster I; Mak TW; Yonekawa H; Penninger JM; Kanaho Y; Suzuki A; Sasaki T
    Nat Cell Biol; 2007 Jan; 9(1):36-44. PubMed ID: 17173042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TREM2- and DAP12-dependent activation of PI3K requires DAP10 and is inhibited by SHIP1.
    Peng Q; Malhotra S; Torchia JA; Kerr WG; Coggeshall KM; Humphrey MB
    Sci Signal; 2010 May; 3(122):ra38. PubMed ID: 20484116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of SHIP1 in Invariant NKT Cell Development and Functions.
    Anderson CK; Salter AI; Toussaint LE; Reilly EC; Fugère C; Srivastava N; Kerr WG; Brossay L
    J Immunol; 2015 Sep; 195(5):2149-2156. PubMed ID: 26232432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.